Consultant Wesley De Jaeghere

Gent ·KBO/BCE: BE 0785.555.092

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
30-09-2025	30-04-2026	17-03-2026	44 d early	2026-00055746
30-09-2024	30-04-2025	11-03-2025	50 d early	2025-00046332
30-09-2023	30-04-2024	31-03-2024	30 d early	2024-00053460

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€362k
Fixed assets	21/28	€125k
Formation expenses	20	€278
Tangible fixed assets	22/27	€125k
Current assets	29/58	€237k
Amounts receivable within one year	40/41	€26k
Investments	50/53	€11k
Cash & bank	54/58	€197k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€362k
Equity	10/15	€175k
Contributions / capital	10/11	€500
Reserves	13	€174k
Amounts payable	17/49	€187k
Amounts payable after one year	17	€42k
Amounts payable within one year	42/48	€145k
Trade debts payable within one year	44	€115k
Income statement
Gross operating margin	9900	€121k
Operating result	9901	€116k
Financial income	75	€2k
Financial charges	65	€2k
Result before taxes	9903	€116k
Income taxes	67/77	€33k
Net result for the period	9904	€82k
Result to be appropriated	9905	€82k

Legal nameNL	Consultant Wesley De Jaeghere
AbbreviationNL	WDJ Pharma

Summary